Armata Pharmaceuticals, Inc. SEC filings ARMP

Armata Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jan 27, 2004. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (other events). The company's fiscal year ends on December 31.

Armata Pharmaceuticals, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Jul 13, 2026 —
424B5 Prospectus supplement Dec 1, 2025 —
S-8 Employee stock plan registration Aug 13, 2025 —
S-3 Shelf registration Aug 13, 2025 —
S-8 Employee stock plan registration Jan 23, 2024 —
S-8 Employee stock plan registration Nov 15, 2023 —
424B3 Prospectus Apr 6, 2023 —
S-3/A Form s-3/a Mar 28, 2023 —
S-3 Shelf registration Feb 13, 2023 —
424B3 Prospectus Jun 1, 2022 —
S-3/A Form s-3/a May 24, 2022 —
S-3 Shelf registration May 16, 2022 —
424B3 Prospectus Apr 6, 2022 —
S-3 Shelf registration Mar 29, 2022 —
424B3 Prospectus May 20, 2021 —
S-3 Shelf registration May 13, 2021 —
S-8 Employee stock plan registration Nov 12, 2020 —
424B3 Prospectus Apr 9, 2020 —
424B3 Prospectus Apr 9, 2020 —
S-3 Shelf registration Apr 1, 2020 —
S-3 Shelf registration Apr 1, 2020 —
FWP Free writing prospectus Jan 9, 2020 —
S-1/A Amended registration statement Jan 9, 2020 —
S-1 Registration statement Dec 20, 2019 —
S-8 Employee stock plan registration Jun 10, 2019 —
424B4 Prospectus Oct 15, 2018 —
S-1/A Amended registration statement Oct 11, 2018 —
S-1/A Amended registration statement Oct 9, 2018 —
S-1/A Amended registration statement Sep 18, 2018 —
S-1 Registration statement Aug 21, 2018 —
S-8 Employee stock plan registration Mar 28, 2018 —
424B5 Prospectus supplement Mar 20, 2018 —
424B5 Prospectus supplement Jan 11, 2018 —
424B5 Prospectus supplement Jan 9, 2018 —
S-1 Registration statement Dec 14, 2017 —
S-8 Employee stock plan registration Nov 14, 2017 —
424B4 Prospectus May 8, 2017 —
S-1MEF Filing May 4, 2017 —
S-1/A Amended registration statement May 4, 2017 —
FWP Free writing prospectus May 2, 2017 —
S-1/A Amended registration statement May 1, 2017 —
S-8 Employee stock plan registration May 1, 2017 —
S-1 Registration statement Apr 6, 2017 —
424B4 Prospectus Nov 17, 2016 —
S-1/A Amended registration statement Nov 16, 2016 —
S-1/A Amended registration statement Nov 14, 2016 —
S-1/A Amended registration statement Nov 10, 2016 —
S-1/A Amended registration statement Oct 3, 2016 —
FWP Free writing prospectus Sep 20, 2016 —
S-1/A Amended registration statement Sep 14, 2016 —
S-1 Registration statement Sep 1, 2016 —
424B3 Prospectus Aug 15, 2016 —
424B3 Prospectus Aug 15, 2016 —
424B3 Prospectus Jun 23, 2016 —
424B3 Prospectus Jun 23, 2016 —
S-8 Employee stock plan registration Jun 22, 2016 —
424B5 Prospectus supplement Jun 1, 2016 —
S-3/A Filing Apr 29, 2016 —
S-3 Shelf registration Apr 28, 2016 —
424B3 Prospectus Apr 21, 2016 —
424B3 Prospectus Apr 21, 2016 —
424B3 Prospectus May 15, 2015 —
S-1/A Amended registration statement May 12, 2015 —
S-8 Employee stock plan registration Apr 16, 2015 —
S-1 Registration statement Apr 16, 2015 —
424B3 Prospectus Jan 5, 2015 —
S-1/A Amended registration statement Dec 24, 2014 —
S-1/A Amended registration statement Nov 20, 2014 —
S-1/A Amended registration statement May 23, 2014 —
S-1/A Amended registration statement Apr 15, 2014 —
S-1/A Amended registration statement Feb 4, 2014 —
S-1 Registration statement Jan 21, 2014 —
S-8 POS Post effective amendment no.1 to form s-8 Mar 5, 2010 —
S-8 POS Post effective amendment no.1 to form s-8 Mar 5, 2010 —
S-8 POS Post effective amendment no.1 to form s-8 Mar 5, 2010 —
S-8 POS Post effective amendment no.1 to form s-8 Mar 5, 2010 —
S-8 POS Post effective amendment no.1 to form s-8 Mar 5, 2010 —
S-8 POS Post effective amendment no.1 to form s-8 Mar 5, 2010 —
S-8 POS Post effective amendment no.1 to form s-8 Mar 5, 2010 —
S-8 POS Post effective amendment no.1 to form s-8 Mar 5, 2010 —
S-8 POS Post effective amendment no.1 to form s-8 Mar 5, 2010 —
POS AM Post effective amendment no. 1 to form s-3 Mar 1, 2010 —
POS AM Post effective amendment no.1 to form s-3 Mar 1, 2010 —
POS AM Post effective amendment no.1 to form s-3 Mar 1, 2010 —
POS AM Post effective amendment no.1 to form s-3 Mar 1, 2010 —
POS AM Post effective amendment no. 1 to form s-3 Mar 1, 2010 —
424B3 Prospectus Jul 31, 2007 —
S-3 Shelf registration Jul 11, 2007 —
S-8 Employee stock plan registration Jun 8, 2007 —
424B3 Prospectus Feb 9, 2007 —
S-3/A Filing Feb 8, 2007 —
S-3 Shelf registration Jan 24, 2007 —
FWP Free writing prospectus Mar 10, 2006 —
424B5 Prospectus supplement Mar 10, 2006 —
424B5 Prospectus supplement Jan 4, 2005 —
424B5 Prospectus supplement Jan 4, 2005 —
POS AM Post effective amendment no. 1 to form s-3 Jun 18, 2004 —
POS AM Post effective amendment no. 1 to form s-3 Jun 18, 2004 —
POS AM Post effective amendment no. 1 to form s-3 Jun 18, 2004 —
POS AM Post effective amendment no. 1 to form s-3 Jun 18, 2004 —
S-8 Employee stock plan registration Jun 17, 2004 —
S-3 Shelf registration Jun 17, 2004 —
424B5 Prospectus supplement Feb 12, 2004 —
424B5 Prospectus supplement Feb 3, 2004 —

Showing 104 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ARMP (NYSE)
Fiscal year ends
December 31
Incorporated in
WA
Headquarters
Los Angeles, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
921114
Former names
AmpliPhi Biosciences Corp (until May 8, 2019); TARGETED GENETICS CORP /WA/ (until Feb 11, 2011)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.